Last updated: July 24, 2024
Sponsor: ContinueYou, LLC
Overall Status: Completed
Phase
2/3
Condition
Stimulant Use Disorder
Addictions
Mood Disorders
Treatment
RAE
Clinical Study ID
NCT05227339
RAEPHASEII
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 years or older
Enrolled in an outpatient SUD treatment program
Enrolled in treatment for < 90 days
Fluent in English
Have access to a smartphone with iOS or Android Capabilities
Capable of providing informed consent
Exclusion
Exclusion Criteria:
Pregnancy
Prisoner Status
Significant limitation of range of motion of non-dominant arm (amputation orfracture)
Study Design
Total Participants: 209
Treatment Group(s): 1
Primary Treatment: RAE
Phase: 2/3
Study Start date:
February 22, 2022
Estimated Completion Date:
April 01, 2024
Study Description
Connect with a study center
University of Massachusetts Chan Medical School
Worcester, Massachusetts 01655
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.